HealthyNCT03637855
Shape Up! Adults Study
An observational study of Healthy, run by University of Hawaii at 1 site in United States.
Trial summary
Identify the unique associations of body shape to body composition indices in a population that represents the variance of sex, age, BMI, and ethnicity found in the US population. Describe the precision and accuracy of 3DO scans to monitor change in body composition and metabolic health interventions. Read more about this study
- Who is it for?
- Ages 18 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- How many people
- 696 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Oct 2016to 31 Dec 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: We will recruit a stratified sample of 720 participants, approximately 360 from each site, using the following equally-weighed stratifications: sex, age (18-40, 40-60, 60-80 years), BMI (less than 25, 25-30, 30 and above) and ethnicity (White, Black, Mexican-American, Asian and Native Hawaiian or Other Pacific Islander). Within this sample, we will include up to 36 participants with very low and high BMI by special recruitments from our facilities Anorexia Nervosa (AN) and bariatric surgery clinics. The remainder of the participants will be recruited as a sample of convenience using local advertisements around our facilities.
Who may be able to join
- Healthy participants will be included in the study if they have a self-reported ability to:
- walk one-quarter of a mile and climb 10 steps without difficulty,
- perform activities of daily living (ADLs) without difficulty, and
- have no life-threatening conditions or diseases that would alter their body composition from what is typical for their age, sex, ethnicity, and BMI.
Who cannot join
- Participants will be excluded if they have any internal metal artifact (e.g. pacemakers, internal fixation, arthroplasty), amputation, physical impairment or previous fracture that would alter body composition assessment or are pregnant or breastfeeding.
- All premenopausal females will be asked for a spot urine sample for pregnancy test prior to participation.
- Those unwilling to comply with this will not be included.
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Hawaii Cancer Center
Honolulu, Hawaii, 96813
About this study
Official title: Optical Body Composition and Health Assessment (Shape Up! Adults) Study
Identify the unique associations of body shape to body composition indices in a population that represents the variance of sex, age, BMI, and ethnicity found in the US population.
Describe the precision and accuracy of 3DO scans to monitor change in body composition and metabolic health interventions.
Estimate the level of association of 3DO to common health indicators including metabolic risk factors (glucose, triglycerides, HDL-cholesterol, blood pressure, VAT, WC and strength) by gender, race, age, and BMI.
Investigate holistic, high-resolution descriptors of 3D body shape as direct predictors of body composition and metabolic risk using statistical shape models and Latent Class Analysis.
- Conditions
- Healthy
What is being measured
The primary outcome is the main question the study is designed to answer.
Fat mass
Measure fat mass and percent fat (arms, legs, trunk, and total) using Dual energy X-ray absorptiometry (DXA) data
Measured: 1 day
Lean mass
Measure lean mass (arms, legs, trunk, and total) using Dual energy X-ray absorptiometry (DXA) data
Measured: 1 day
Bone mass
Measure bone mass (arms, legs, lumbar spine, and total) and Bone Mineral Density (spine and total)
Measured: 1 day
Waist to Hip ratio (WHR) from manual tape measurement
Manual physical anthropometry of waist and hip circumferences
Measured: 1 day
Automatic 3D optical (3DO) scan measurement
Automated 3DO measurements generate the following: 476 girth, length, and volume measurements across the whole body.
Measured: 1 day
HUMAC NORM
Will measure isokinetic strength of knee and back to assess muscle function
Measured: 1 day
Jamar hydraulic hand dynamometer
Will measure grip strength to assess muscle function
Measured: 1 day
Fasting glucose levels
Measure fasting glucose levels
Measured: 1 day
Fasting HbA1c levels
Measure fasting HbA1c levels
Measured: 1 day
Fasting insulin levels
Measure fasting insulin levels
Measured: 1 day
Fasting cholesterol levels
Measure fasting cholesterol levels
Measured: 1 day
Fasting triglycerides levels
Measure fasting triglycerides levels
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Aug 2018
- Study start1 Oct 2016
- Primary completion31 Dec 2021
- Study completion31 Dec 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (11)Papers the sponsor has linked to this study.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 696 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Hawaii
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- John Shepherd, PhD, Principal investigator, University of Hawaii Cancer Research Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03637855
- Sponsor's protocol ID
- R01DK109008
- Status last verified
- May 2022
- First submitted
- 19 Jul 2018
- Last updated
- 9 May 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Bennett JP, Wong MC, Liu YE, Quon BK, Kelly NN, Garber AK, Heymsfield SB, Shepherd JA. Trunk-to-leg volume and appendicular lean mass from a commercial 3-dimensional optical body scanner for disease risk identification. Clin Nutr. 2024 Oct;43(10):2430-2437. doi: 10.1016/j.clnu.2024.09.028. Epub 2024 Sep 16.
PubMed 39305753Marazzato F, McCarthy C, Field RH, Nguyen H, Nguyen T, Shepherd JA, Tinsley GM, Heymsfield SB. Advances in digital anthropometric body composition assessment: neural network algorithm prediction of appendicular lean mass. Eur J Clin Nutr. 2024 May;78(5):452-454. doi: 10.1038/s41430-023-01396-3. Epub 2023 Dec 23.
PubMed 38142263Garber AK, Bennett JP, Wong MC, Tian IY, Maskarinec G, Kennedy SF, McCarthy C, Kelly NN, Liu YE, Machen VI, Heymsfield SB, Shepherd JA. Cross-sectional assessment of body composition and detection of malnutrition risk in participants with low body mass index and eating disorders using 3D optical surface scans. Am J Clin Nutr. 2023 Oct;118(4):812-821. doi: 10.1016/j.ajcnut.2023.08.004. Epub 2023 Aug 19.
PubMed 37598747Wong MC, Bennett JP, Quon B, Leong LT, Tian IY, Liu YE, Kelly NN, McCarthy C, Chow D, Pujades S, Garber AK, Maskarinec G, Heymsfield SB, Shepherd JA. Accuracy and Precision of 3-dimensional Optical Imaging for Body Composition by Age, BMI, and Ethnicity. Am J Clin Nutr. 2023 Sep;118(3):657-671. doi: 10.1016/j.ajcnut.2023.07.010. Epub 2023 Jul 19.
PubMed 37474106McCarthy C, Tinsley GM, Yang S, Irving BA, Wong MC, Bennett JP, Shepherd JA, Heymsfield SB. Smartphone prediction of skeletal muscle mass: model development and validation in adults. Am J Clin Nutr. 2023 Apr;117(4):794-801. doi: 10.1016/j.ajcnut.2023.02.003. Epub 2023 Feb 8.
PubMed 36822238Wong MC, Bennett JP, Leong LT, Tian IY, Liu YE, Kelly NN, McCarthy C, Wong JMW, Ebbeling CB, Ludwig DS, Irving BA, Scott MC, Stampley J, Davis B, Johannsen N, Matthews R, Vincellette C, Garber AK, Maskarinec G, Weiss E, Rood J, Varanoske AN, Pasiakos SM, Heymsfield SB, Shepherd JA. Monitoring body composition change for intervention studies with advancing 3D optical imaging technology in comparison to dual-energy X-ray absorptiometry. Am J Clin Nutr. 2023 Apr;117(4):802-813. doi: 10.1016/j.ajcnut.2023.02.006. Epub 2023 Feb 14.
PubMed 36796647Wong MC, McCarthy C, Fearnbach N, Yang S, Shepherd J, Heymsfield SB. Emergence of the obesity epidemic: 6-decade visualization with humanoid avatars. Am J Clin Nutr. 2022 Apr 1;115(4):1189-1193. doi: 10.1093/ajcn/nqac005.
PubMed 35030235Panizza CE, Wong MC, Kelly N, Liu YE, Shvetsov YB, Lowe DA, Weiss EJ, Heymsfield SB, Kennedy S, Boushey CJ, Maskarinec G, Shepherd JA. Diet Quality and Visceral Adiposity among a Multiethnic Population of Young, Middle, and Older Aged Adults. Curr Dev Nutr. 2020 May 26;4(6):nzaa090. doi: 10.1093/cdn/nzaa090. eCollection 2020 Jun.
PubMed 33959689Lowe DA, Wu N, Rohdin-Bibby L, Moore AH, Kelly N, Liu YE, Philip E, Vittinghoff E, Heymsfield SB, Olgin JE, Shepherd JA, Weiss EJ. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial. JAMA Intern Med. 2020 Nov 1;180(11):1491-1499. doi: 10.1001/jamainternmed.2020.4153.
PubMed 32986097Harty PS, Sieglinger B, Heymsfield SB, Shepherd JA, Bruner D, Stratton MT, Tinsley GM. Novel body fat estimation using machine learning and 3-dimensional optical imaging. Eur J Clin Nutr. 2020 May;74(5):842-845. doi: 10.1038/s41430-020-0603-x. Epub 2020 Mar 16.
PubMed 32203233Ng BK, Sommer MJ, Wong MC, Pagano I, Nie Y, Fan B, Kennedy S, Bourgeois B, Kelly N, Liu YE, Hwaung P, Garber AK, Chow D, Vaisse C, Curless B, Heymsfield SB, Shepherd JA. Detailed 3-dimensional body shape features predict body composition, blood metabolites, and functional strength: the Shape Up! studies. Am J Clin Nutr. 2019 Dec 1;110(6):1316-1326. doi: 10.1093/ajcn/nqz218.
PubMed 31553429
Study at a glance
From the registry record, last updated by the sponsor on 9 May 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Optical Body Composition and Health Assessment (Shape Up! Adults) Study
- ClinicalTrials.gov ID
- NCT03637855
- Acronym / sponsor ID
- R01DK109008
- Conditions
- Healthy
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 696 participants (actual)
- Lead sponsor
- University of HawaiiUniversity, hospital or other
- Study start
- 1 Oct 2016 (actual)
- Primary completion
- 31 Dec 2021 (actual)
- Study completion
- 31 Dec 2021 (actual)
- First posted
- 20 Aug 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Identify the unique associations of body shape to body composition indices in a population that represents the variance of sex, age, BMI, and ethnicity found in the US population.
Describe the precision and accuracy of 3DO scans to monitor change in body composition and metabolic health interventions.
Estimate the level of association of 3DO to common health indicators including metabolic risk factors (glucose, triglycerides, HDL-cholesterol, blood pressure, VAT, WC and strength) by gender, race, age, and BMI.
Investigate holistic, high-resolution descriptors of 3D body shape as direct predictors of body composition and metabolic risk using statistical shape models and Latent Class Analysis.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- We will recruit a stratified sample of 720 participants, approximately 360 from each site, using the following equally-weighed stratifications: sex, age (18-40, 40-60, 60-80 years), BMI (less than 25, 25-30, 30 and above) and ethnicity (White, Black, Mexican-American, Asian and Native Hawaiian or Other Pacific Islander). Within this sample, we will include up to 36 participants with very low and high BMI by special recruitments from our facilities Anorexia Nervosa (AN) and bariatric surgery clinics. The remainder of the participants will be recruited as a sample of convenience using local advertisements around our facilities.
Key inclusion criteria (4 listed)
- Healthy participants will be included in the study if they have a self-reported ability to:
Key exclusion criteria (3 listed)
- Participants will be excluded if they have any internal metal artifact (e.g. pacemakers, internal fixation, arthroplasty), amputation, physical impairment or previous fracture that would alter body composition assessment or are pregnant or breastfeeding.
- All premenopausal females will be asked for a spot urine sample for pregnancy test prior to participation.
- Those unwilling to comply with this will not be included.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Fat mass
Time frame: 1 day
Measure fat mass and percent fat (arms, legs, trunk, and total) using Dual energy X-ray absorptiometry (DXA) data
Lean mass
Time frame: 1 day
Measure lean mass (arms, legs, trunk, and total) using Dual energy X-ray absorptiometry (DXA) data
Bone mass
Time frame: 1 day
Measure bone mass (arms, legs, lumbar spine, and total) and Bone Mineral Density (spine and total)
Waist to Hip ratio (WHR) from manual tape measurement
Time frame: 1 day
Manual physical anthropometry of waist and hip circumferences
Automatic 3D optical (3DO) scan measurement
Time frame: 1 day
Automated 3DO measurements generate the following: 476 girth, length, and volume measurements across the whole body.
HUMAC NORM
Time frame: 1 day
Will measure isokinetic strength of knee and back to assess muscle function
Jamar hydraulic hand dynamometer
Time frame: 1 day
Will measure grip strength to assess muscle function
Fasting glucose levels
Time frame: 1 day
Measure fasting glucose levels
Fasting HbA1c levels
Time frame: 1 day
Measure fasting HbA1c levels
Fasting insulin levels
Time frame: 1 day
Measure fasting insulin levels
Fasting cholesterol levels
Time frame: 1 day
Measure fasting cholesterol levels
Fasting triglycerides levels
Time frame: 1 day
Measure fasting triglycerides levels
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 May 2022.
- Derived from this study: PubMed 39305753Bennett JP, Wong MC, Liu YE, Quon BK, Kelly NN, Garber AK, Heymsfield SB, Shepherd JA. Trunk-to-leg volume and appendicular lean mass from a commercial 3-dimensional optical body scanner for disease risk identification. Clin Nutr. 2024 Oct;43(10):2430-2437. doi: 10.1016/j.clnu.2024.09.028. Epub 2024 Sep 16.
- Derived from this study: PubMed 38142263Marazzato F, McCarthy C, Field RH, Nguyen H, Nguyen T, Shepherd JA, Tinsley GM, Heymsfield SB. Advances in digital anthropometric body composition assessment: neural network algorithm prediction of appendicular lean mass. Eur J Clin Nutr. 2024 May;78(5):452-454. doi: 10.1038/s41430-023-01396-3. Epub 2023 Dec 23.
- Derived from this study: PubMed 37598747Garber AK, Bennett JP, Wong MC, Tian IY, Maskarinec G, Kennedy SF, McCarthy C, Kelly NN, Liu YE, Machen VI, Heymsfield SB, Shepherd JA. Cross-sectional assessment of body composition and detection of malnutrition risk in participants with low body mass index and eating disorders using 3D optical surface scans. Am J Clin Nutr. 2023 Oct;118(4):812-821. doi: 10.1016/j.ajcnut.2023.08.004. Epub 2023 Aug 19.
- Derived from this study: PubMed 37474106Wong MC, Bennett JP, Quon B, Leong LT, Tian IY, Liu YE, Kelly NN, McCarthy C, Chow D, Pujades S, Garber AK, Maskarinec G, Heymsfield SB, Shepherd JA. Accuracy and Precision of 3-dimensional Optical Imaging for Body Composition by Age, BMI, and Ethnicity. Am J Clin Nutr. 2023 Sep;118(3):657-671. doi: 10.1016/j.ajcnut.2023.07.010. Epub 2023 Jul 19.
- Derived from this study: PubMed 36822238McCarthy C, Tinsley GM, Yang S, Irving BA, Wong MC, Bennett JP, Shepherd JA, Heymsfield SB. Smartphone prediction of skeletal muscle mass: model development and validation in adults. Am J Clin Nutr. 2023 Apr;117(4):794-801. doi: 10.1016/j.ajcnut.2023.02.003. Epub 2023 Feb 8.
- Derived from this study: PubMed 36796647Wong MC, Bennett JP, Leong LT, Tian IY, Liu YE, Kelly NN, McCarthy C, Wong JMW, Ebbeling CB, Ludwig DS, Irving BA, Scott MC, Stampley J, Davis B, Johannsen N, Matthews R, Vincellette C, Garber AK, Maskarinec G, Weiss E, Rood J, Varanoske AN, Pasiakos SM, Heymsfield SB, Shepherd JA. Monitoring body composition change for intervention studies with advancing 3D optical imaging technology in comparison to dual-energy X-ray absorptiometry. Am J Clin Nutr. 2023 Apr;117(4):802-813. doi: 10.1016/j.ajcnut.2023.02.006. Epub 2023 Feb 14.
- Derived from this study: PubMed 35030235Wong MC, McCarthy C, Fearnbach N, Yang S, Shepherd J, Heymsfield SB. Emergence of the obesity epidemic: 6-decade visualization with humanoid avatars. Am J Clin Nutr. 2022 Apr 1;115(4):1189-1193. doi: 10.1093/ajcn/nqac005.
- Derived from this study: PubMed 33959689Panizza CE, Wong MC, Kelly N, Liu YE, Shvetsov YB, Lowe DA, Weiss EJ, Heymsfield SB, Kennedy S, Boushey CJ, Maskarinec G, Shepherd JA. Diet Quality and Visceral Adiposity among a Multiethnic Population of Young, Middle, and Older Aged Adults. Curr Dev Nutr. 2020 May 26;4(6):nzaa090. doi: 10.1093/cdn/nzaa090. eCollection 2020 Jun.
- Derived from this study: PubMed 32986097Lowe DA, Wu N, Rohdin-Bibby L, Moore AH, Kelly N, Liu YE, Philip E, Vittinghoff E, Heymsfield SB, Olgin JE, Shepherd JA, Weiss EJ. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial. JAMA Intern Med. 2020 Nov 1;180(11):1491-1499. doi: 10.1001/jamainternmed.2020.4153.
- Derived from this study: PubMed 32203233Harty PS, Sieglinger B, Heymsfield SB, Shepherd JA, Bruner D, Stratton MT, Tinsley GM. Novel body fat estimation using machine learning and 3-dimensional optical imaging. Eur J Clin Nutr. 2020 May;74(5):842-845. doi: 10.1038/s41430-020-0603-x. Epub 2020 Mar 16.
- Derived from this study: PubMed 31553429Ng BK, Sommer MJ, Wong MC, Pagano I, Nie Y, Fan B, Kennedy S, Bourgeois B, Kelly N, Liu YE, Hwaung P, Garber AK, Chow D, Vaisse C, Curless B, Heymsfield SB, Shepherd JA. Detailed 3-dimensional body shape features predict body composition, blood metabolites, and functional strength: the Shape Up! studies. Am J Clin Nutr. 2019 Dec 1;110(6):1316-1326. doi: 10.1093/ajcn/nqz218.
Related trials for Healthy
Not yet recruitingPhase 2
Investigating the Analgesic Potential of (2R,6R)-HNK in Acute Pain in Healthy Volunteers
Healthy Volunteers
RecruitingObservational study
Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers
Healthy Volunteers
RecruitingPhase 1
Bioequivalence Study Between YHP2508A and YHR2601 in Healthy Subjects
Healthy Subjects (HS)
Not yet recruitingObservational study
Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
Healthy Volunteer, Obestity
RecruitingObservational study
Relationship Between Great Toe Strength And Symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Chemotherapy-induced Peripheral Neuropathy (CIPN), Healthy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
John Shepherd, PhD principal investigator
University of Hawaii Cancer Research Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Healthy, run by University of Hawaii at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 May 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Fat mass (time frame: 1 day). The study lists 12 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03637855, which also lists 11 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 May 2022.